Clinical trial
Study of INS115644 Ophthalmic Solution in Subjects With Ocular Hypertension or…
NCT00443924 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00443924 |
|---|---|
| Title | Study of INS115644 Ophthalmic Solution in Subjects With Ocular Hypertension or Glaucoma |
| Official title | A Multi-Center, Double-Masked, Randomized, Placebo-Controlled, Ascending Dose Study of INS115644 Ophthalmic Solution in Subjects With Bilateral Ocular Hypertension or Early Primary Open Angle Glaucoma |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Ocular Hypertension, Open Angle Glaucoma |
| Intervention type | Drug |
| Interventions | INS115644 Ophthalmic Solution, Placebo |
| Enrollment | 56 |
| Start date | Mar 1, 2007 |
| Primary completion | Apr 1, 2009 |
| Completion | Apr 1, 2009 |
| First posted | Mar 7, 2007 |
| Last update posted | Jan 21, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: